EUCTR2007-004085-41-GBActive, not recruitingNot Applicable
Photodynamic Therapy for Basal Cell Carcinoma of the Eyelid and Periocular Skin with methyl aminolevulinate - PDT for periocular BCC
The Royal Wolverhampton Hospitals NHS Trust0 sites15 target enrollmentStarted: April 4, 2008Last updated:
Conditions
Drugs
Trial Snapshot
- Phase
- Not Applicable
- Status
- Active, not recruiting
- Enrollment
- 15
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional clinical trial of medicinal product
Eligibility Criteria
- Sex
- All
Inclusion Criteria
- •Primary Basal cell carcinoma in the lid or periocular region, sparing the lid margin by at least 5 mm
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years)
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years)
- •F.1.3.1 Number of subjects for this age range
Exclusion Criteria
- •-Recurrent BCCs
- •-A past medical history of skin disease or allergy ( especially to arachis oil ) which may be potentially likely to interfere with the treatment
- •-A past medical history of porphyria
- •-Pregnant and lactating mothers
- •-Morpheaform BCC
Investigators
Similar Trials
Active, not recruiting
Phase 1
Optimized photodynamic therapy for skin cancerMedDRA version: 19.0Level: PTClassification code 10004146Term: Basal cell carcinomaSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)Basal cell carcinomaEUCTR2016-002508-16-DKDepartment of Dermatology D92, Bispebjerg Hospital50
Active, not recruiting
Not Applicable
Superficially growing basal cell cancer's light activation treatment: comparing three light sensitising creamsEUCTR2014-002746-50-FIMari Salmivuori
Recruiting
Phase 3
Treatment of superficial basal cell carcinoma by topical photodynamic therapy with fractionated 5-aminolevulinic acid 20% versus two stage topical photodynamic therapy with methylaminolevulinate10040900skin cancerBasal cell carcinomaNL-OMON50578Medisch Universitair Ziekenhuis Maastricht162
Active, not recruiting
Not Applicable
Superficiel basal cell carcinoma treatment with topical photodynamic therapy with fractionated 5-aminolevulinic acid 20% versus two stage methylaminolevulateSuperficial basal cell carcinomaEUCTR2011-005809-77-NLMaastricht University Medical Centre
Active, not recruiting
Not Applicable
Treatment of superficial basal cell carcinoma by three non-invasive modalities: PDT vs. imiquimod vs. 5-fluorouracil - Treatment of sBCCsuperficial basal cell carcinomaEUCTR2007-002776-33-NLAcademic hospital Maastricht